Q1 2025 Heartbeam Inc Earnings Call Transcript

May 13, 2025 / 08:30 PM GMT

Transcript 10-Q

Key Points

Positve

HeartBeam Inc (BEAT) received foundational FDA 510k clearance for its Heartbeam System, marking a significant regulatory milestone.
The company achieved important milestones, including a strategic collaboration with Acucardia and the presentation of valid ECG study results.
HeartBeam Inc (BEAT) has a strong intellectual property position with 20 issued patents worldwide, enhancing its competitive edge.
The early access program is providing valuable feedback, helping refine the product and prepare for commercial launch.
The company raised $11.5 million through a public offering, strengthening its financial position for upcoming commercialization efforts.

Negative

HeartBeam Inc (BEAT) is still awaiting FDA clearance for its 12-lead synthesis software, which is crucial for commercialization.
The company faces potential challenges in scaling its manufacturing capabilities and managing supply chain complexities.
There is uncertainty regarding the exact timing of the commercial launch, which is dependent on FDA clearance.
HeartBeam Inc (BEAT) is operating in a competitive market, and its success depends on differentiating its product effectively.
The company is incurring significant expenses related to R&D and commercial readiness, impacting its cash flow.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BEAT.OQ - Heartbeam Inc
Q1 2025 Heartbeam Inc Earnings Call
May 13, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Heartbeam first quarter 2025 financial results conference call.

At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference call is being recorded.

Before we begin, The formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates, or other information that might be considered forward-looking.

While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially.

You are cautioned not to place

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.